Taking two injections within 48 to 72 hours can lead to serious side effects, including persistent vomiting, which could indicate pancreatitis
In the randomized Semaglutide Treatment Effect in People with Obesity (STEP) 1 trial (intent to treat: 1,961 adults with overweight or obesity without T2D), once-weekly subcutaneous semaglutide 2.4 mg resulted in greater weight loss compared with placebo over a 68-week period (estimated treatment difference 12.4 percentage points, 95% confidence interval (CI) 13.4, 11.5
Communication could have been better but, the product works
Bone health monitoring Rapid weight loss from any cause, including GLP-1 therapy, can accelerate bone density loss, particularly in postmenopausal women
Yes, Wegovy (semaglutide) is available on a private prescription in the UK for weight loss